trending Market Intelligence /marketintelligence/en/news-insights/trending/kIlfRRlfmxy2qXFOLT6Xrw2 content esgSubNav
In This List

German court dismisses Novartis appeal against Luye Pharma

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


German court dismisses Novartis appeal against Luye Pharma

The Court of Appeal for the district of Munich in Germany dismissed Novartis AG's appeal in a patent infringement lawsuit against Luye Pharma Group Ltd.'s Rivastigmine 1 day patch, a treatment for Alzheimer's disease.

Novartis also reimbursed the company of relevant legal expenses.